Toward earlier detection of choroidal neovascularization secondary to age-related macular degeneration: Multicenter evaluation of a preferential hyperacuity perimeter designed as a home device

Retina

Volumn 30, Issue 7, 2010, Pages 1058-1064

  Loewenstein, Anat ^p   Ferencz, Joseph R ^a   Lang, Yaron ^b   Yeshurun, Itamar ^c   Pollack, Ayala ^d   Siegal, Ruth ^e   Lifshitz, Tova ^f   Karp, Joseph ^g   Roth, Daniel ^h   Bronner, Guri ⁱ   Brown, Justin ^j   Mansour, Sam ^k   Friedman, Scott ^l   Michels, Mark ^m   Johnston, Richards ⁿ   Rapp, Moshe ^o   Havilio, Moshe ^o   Rafaeli, Omer ^o   Manor, Yair ^o  

^a MEIR MEDICAL CENTER   (Israel)

^b HAEMEK MEDICAL CENTER   (Israel)

^c WOLFSON MEDICAL CENTER   (Israel)

^d KAPLAN MEDICAL CENTER   (Israel)

^e RABIN MEDICAL CENTER   (Israel)

^f BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^g Machon Mor   (Israel)

^h Retina Vitreous Center   (United States)

ⁱ Foxman Foxman and Margolis   (United States)

^j Charlotte Eye Ear Nose and Throat Associates   (United States)

^k Virginia Retina Center   (United States)

^l Central Florida Retina Institute   (United States)

^m Retina Care Specialists   (United States)

ⁿ Edina Retina Consultants   (United States)

^o Notal Vision LTD   (Israel)

^p NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MULTICENTER STUDY; PERIMETER; PREFERENTIAL HYPERACUITY PERIMETER; PROSPECTIVE STUDY; RETINA MACULA AGE RELATED DEGENERATION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SUBRETINAL NEOVASCULARIZATION;

AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; EARLY DIAGNOSIS; EQUIPMENT DESIGN; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PERIMETRY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SELF CARE; SENSITIVITY AND SPECIFICITY; VISUAL ACUITY;

EID: 77954760176     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181d1a75e     Document Type: Article

References (26)

1. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355:1432-1444.
2. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-1431.
3. Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial. Ophthalmology 2008;115:1474-1479.
4. Olsen TW, Feng X, Kasper TJ, Rath PP, Steuer ER. Fluores-cein angiographic lesion type frequency in neovascular age-related macular degeneration. Ophthalmology 2004;111:250-255. (Pubitemid 38183223)
5. Boyer DS, Antoszyk AN, Awh CC, Bhisitkul RB, Shapiro H, Acharya NR. Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 2007;114:246-252.
6. Kaiser PK, Brown DM, Zhang K, et al. Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol 2007;144:850-857.
7. Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Macular Photocoagulation Study Group. Arch Ophthalmol 1993;111:1189-1199.
8. Brown DM,MichelsM, Kaiser PK, Heier JS, Sy JP, Ianchulev T. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 2009;116:57-65.
9. Bedell HE, Tong J, Woo SY, House JR, Nguyen T. Orientation discrimination with macular changes associated with early AMD. Optom Vis Sci 2009;86:485-491.
10. Neelam K, Nolan J, Chakravarthy U, Beatty S. Psychophysical function in age-related maculopathy. Surv Ophthalmol 2009; 54:167-210.
11. Loewenstein A. The significance of early detection of agerelated macular degeneration: Richard & Hinda Rosenthal Foundation Lecture, The Macula Society 29th Annual Meeting. Retina 2007;27:873-878.
12. Fine AM, Elman MJ, Ebert JE, Prestia PA, Starr JS, Fine SL. Earliest symptoms caused by neovascular membranes in the macula. Arch Ophthalmol 1986;104:513-514.
13. Achard OA, Safran AB, Duret FC, Ragama E. Role of the completion phenomenon in the evaluation of Amsler grid results. Am J Ophthalmol 1995;120:322-329.
14. Zaidi FH, Cheong-Leen R, Gair EJ, et al. The Amsler chart is of doubtful value in retinal screening for early laser therapy of subretinal membranes. The West London Survey. Eye (Lond) 2004;18:503-508.
15. Loewenstein A, Malach R, Goldstein M, et al. Replacing the Amsler grid: a new method for monitoring patients with age-related macular degeneration. Ophthalmology 2003;110: 966-970.
16. Alster Y, Bressler NM, Bressler SB, et al. Preferential hyperacuity perimeter (PreView) for detecting choroidal neovascularization study. Ophthalmology 2005;112:1758-1765.
17. Goldstein M, Loewenstein A, Barak A, et al. Results of a multicenter clinical trial to evaluate the preferential hyperacu- ity perimeter for detection of age-related macular degeneration. Retina 2005;25:296-303.
18. Kampmeier J, Zorn MM, Lang GK, Botros YT, Lang GE. Comparison of Preferential Hyperacuity Perimeter (PHP) test and Amsler grid test in the diagnosis of different stages of agerelated macular degeneration [in German]. Klin Monatsbl Augenheilkd 2006;223:752-756.
19. Klatt C, Sendtner P, Ponomareva L, et al. Diagnostics of metamorphopsia in retinal diseases of different origins [in German]. Ophthalmologe 2006;103:945-952.
20. Isaac DL, Avila MP, Cialdini AP. Comparison of the original Amsler grid with the preferential hyperacuity perimeter for detecting choroidal neovascularization in age-related macular degeneration. Arq Bras Oftalmol 2007;70:771-776.
21. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001;119: 1417-1436.
22. Solomon SD, Bressler SB, Hawkins BS,MarshMJ, Bressler NM. Guidelines for interpreting retinal photographs and coding findings in the Submacular Surgery Trials (SST): SST report no. 8. Retina 2005;25:253-268.
23. Vander JF, Morgan CM, Schatz H. Growth rate of subretinal neovascularization in age-related macular degeneration. Ophthalmology 1989;96:1422-1426; discussion 1426-1429.
24. Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1982; 100:912-918.
25. Bressler NM, Frost LA, Bressler SB, Murphy RP, Fine SL. Natural course of poorly defined choroidal neovascularization associated with macular degeneration. Arch Ophthalmol 1988; 106:1537-1542.
26. Macular Photocoagulation Study (MPS) Group. Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Arch Ophthalmol 1996;114:400-412.